Literature DB >> 15152074

Priming with granulocyte colony-stimulating factor--relation to high-dose cytarabine in acute myeloid leukemia.

Thomas Büchner, Wolfgang E Berdel, Wolfgang Hiddemann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15152074     DOI： 10.1056/NEJM200405203502124

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  Age, not therapy intensity, determines outcomes of adults with acute myeloid leukemia.

Authors:  T Büchner; U O Krug; R Peter Gale; A Heinecke; M C Sauerland; C Haferlach; S Schnittger; T Haferlach; C Müller-Tidow; M Stelljes; R M Mesters; H L Serve; J Braess; K Spiekermann; P Staib; A Grüneisen; A Reichle; L Balleisen; H Eimermacher; A Giagounidis; H Rasche; E Lengfelder; D Görlich; A Faldum; W Köpcke; R Hehlmann; B J Wörmann; W E Berdel; W Hiddemann
Journal:  Leukemia       Date:  2016-03-11       Impact factor: 11.528

2.  Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 study.

Authors:  Sergio Amadori; Stefan Suciu; Ulrich Jehn; Roberto Stasi; Xavier Thomas; Jean-Pierre Marie; Petra Muus; Francois Lefrère; Zwi Berneman; George Fillet; Claudio Denzlinger; Roel Willemze; Pietro Leoni; Giuseppe Leone; Marco Casini; Francesco Ricciuti; Marco Vignetti; Filip Beeldens; Franco Mandelli; Theo De Witte
Journal:  Blood       Date:  2005-03-10       Impact factor: 22.113

Review 3.  Colony-stimulating factors for prevention and treatment of infectious complications in patients with acute myelogenous leukemia.

Authors:  Ronit Gurion; Yulia Belnik-Plitman; Anat Gafter-Gvili; Mical Paul; Liat Vidal; Isaac Ben-Bassat; Ofer Shpilberg; Pia Raanani
Journal:  Cochrane Database Syst Rev       Date:  2012-06-13

4.  Induction of cell cycle entry eliminates human leukemia stem cells in a mouse model of AML.

Authors:  Yoriko Saito; Naoyuki Uchida; Satoshi Tanaka; Nahoko Suzuki; Mariko Tomizawa-Murasawa; Akiko Sone; Yuho Najima; Shinsuke Takagi; Yuki Aoki; Atsushi Wake; Shuichi Taniguchi; Leonard D Shultz; Fumihiko Ishikawa
Journal:  Nat Biotechnol       Date:  2010-02-14       Impact factor: 54.908

5.  Niche displacement of human leukemic stem cells uniquely allows their competitive replacement with healthy HSPCs.

Authors:  Allison L Boyd; Clinton J V Campbell; Claudia I Hopkins; Aline Fiebig-Comyn; Jennifer Russell; Jelena Ulemek; Ronan Foley; Brian Leber; Anargyros Xenocostas; Tony J Collins; Mickie Bhatia
Journal:  J Exp Med       Date:  2014-09-01       Impact factor: 14.307

Review 6.  To wake up cancer stem cells, or to let them sleep, that is the question.

Authors:  Shoichiro Takeishi; Keiichi I Nakayama
Journal:  Cancer Sci       Date:  2016-06-20       Impact factor: 6.716
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.